BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Korompay N, Alshammari M, Klass D, Chou FY, Chung J, Ho S, Liu DM. Intraprocedural Parenchymal Blood Volume Is a Predictor of Treatment Response for Chemoembolization in Hepatocellular Carcinoma: Results of a Prospective Study. J Vasc Interv Radiol 2018;29:928-35. [PMID: 29752139 DOI: 10.1016/j.jvir.2018.01.783] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Habbel VSA, Zeile M, Stavrou GA, Wacker F, Brüning R, Oldhafer KJ, Rodt T. Correlation between SACE (Subjective Angiographic Chemoembolization Endpoint) score and tumor response and its impact on survival after DEB-TACE in patients with hepatocellular carcinoma. Abdom Radiol (NY) 2019;44:3463-79. [PMID: 31332502 DOI: 10.1007/s00261-019-02128-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li X, Xu M, Liu M, Tan Y, Zhuang B, Lin M, Kuang M, Xie X. Contrast-enhanced ultrasound-guided feeding artery ablation as add-on to percutaneous radiofrequency ablation for hypervascular hepatocellular carcinoma with a modified ablative technique and tumor perfusion evaluation. Int J Hyperthermia 2020;37:1016-26. [PMID: 32865050 DOI: 10.1080/02656736.2020.1811902] [Reference Citation Analysis]